Silencing or not silencing <i>p63</i> in cardiac fibroblast, risks and benefits.

Díaz-Araya, Guillermo; Espitia-Corredor, Jenaro Antonio

Silencing or not silencing p63 in cardiac fibroblast, risks and benefits.

Díaz-Araya, Guillermo; Espitia-Corredor, Jenaro Antonio.

Afiliação

Díaz-Araya G; Molecular Pharmacology Laboratory, Department of Chemical Pharmacology and Toxicology, Advanced Center of Chronic Diseases (ACCDiS), Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.
Espitia-Corredor JA; Molecular Pharmacology Laboratory, Department of Chemical Pharmacology and Toxicology, Advanced Center of Chronic Diseases (ACCDiS), Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.

J Thorac Dis ; 10(10): 5648-5651, 2018 Oct.

Article em En | MEDLINE | ID: mdl-30505469

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: J Thorac Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Chile País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google